Cabot Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Cabot Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$309K	Hold	629	–	–	0.04%	120
2025 Q4	$364K	Sell	629 -9	-1%	-$5.09K	0.04%	113
2025 Q3	$309K	Hold	638	–	–	0.03%	122
2025 Q2	$259K	Hold	638	–	–	0.03%	121
2025 Q1	$317K	Hold	638	–	–	0.04%	110
2024 Q4	$332K	Hold	638	–	–	0.04%	105
2024 Q3	$395K	Sell	638 -25	-4%	-$14.8K	0.05%	107
2024 Q2	$367K	Hold	663	–	–	0.05%	115
2024 Q1	$385K	Hold	663	–	–	0.05%	122
2023 Q4	$352K	Buy	663 +9	+1%	+$4.36K	0.05%	124
2023 Q3	$331K	Buy	654 +7	+1%	+$3.73K	0.05%	123
2023 Q2	$338K	Hold	647	–	–	0.05%	123
2023 Q1	$373K	Hold	647	–	–	0.06%	117
2022 Q4	$356K	Sell	647 -413	-39%	-$219K	0.06%	120
2022 Q3	$538K	Buy	1,060 +25	+2%	+$14K	0.09%	111
2022 Q2	$562K	Hold	1,035	–	–	0.09%	114
2022 Q1	$611K	Hold	1,035	–	–	0.08%	112
2021 Q4	$691K	Hold	1,035	–	–	0.09%	109
2021 Q3	$591K	Hold	1,035	–	–	0.08%	114
2021 Q2	$522K	Sell	1,035 -4	-0.4%	-$1.89K	0.07%	117
2021 Q1	$474K	Buy	1,039 +295	+40%	+$141K	0.07%	114
2020 Q4	$347K	Buy	744 +122	+20%	+$57.2K	0.05%	121
2020 Q3	$275K	Buy	622 +52	+9%	+$21.5K	0.05%	121
2020 Q2	$206K	Buy	+570	New	+$191K	0.04%	129

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cabot Wealth Management's TMO Position: Q1 2026 in Review

Cabot Wealth Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 629 shares worth $309K. The position accounts for 0.04% of the portfolio, ranked #120.

Cabot Wealth Management first reported a position in TMO in Q2 2020 and has held it in 24 quarters since. The position peaked at $691K in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Cabot Wealth Management held 629 shares of Thermo Fisher Scientific worth $309K as of Q1 2026.
Cabot Wealth Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.04% of Cabot Wealth Management's portfolio in Q1 2026, its #120 holding.
Cabot Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 24 quarters since.
Cabot Wealth Management's Thermo Fisher Scientific position peaked at $691K in Q4 2021.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Cabot Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.